LPCN vs PHM · rev $309.5K vs P/E 7.7, rev $7.39B
Lipocine Inc (LPCN) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
LPCN currently screens at market cap $19.3M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the LPCN and PHM stock pages for the full models.
Not investment advice.